This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • KRAS as a druggable target in NSCLC: Rising like a...

KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

Read time: 1 mins
Published:31st Mar 2020
Author: Friedlaender A, Drilon A, Weiss GJ, Banna GL, Addeo A.
Availability: Free full text
Ref.:Cancer Treat Rev. 2020 Apr;85:101978.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest